The relevance of TGF-β1 and PAI-1 is further supported by a recent clinical study in which variants of TGF-β1 and PAI-1 genes were shown to be possible risk factors for cardiovascular disease in patients after radiotherapy for breast cancer [38]. The gene discussed is SERPINE1; the disease is breast carcinoma.